Kakao Ventures

Kakao Ventures is one of South Korea’s most active early-stage venture capital firms focused on seed to growth-stage investments across technology sectors including deep tech and digital healthcare. It does not itself develop drugs or medical devices but has invested in several medtech/digital health startups such as Vivid Health—a platform supporting users of GLP‑1 obesity medications—and Compass—a U.S.-based medtech firm. The firm operates independently under parent company Kakao Corp., manages over $300M AUM as of mid‑2020s, has made hundreds of startup investments globally—including increasing activity outside Korea—and remains active with no acquisition history reported up to June 2025[1][2][3][4].